ReviewSeminars in interventional radiology2025
The Role of IR in Pediatric Liver Cancer.
Review in Seminars in interventional radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Despite the well-defined role of interventional radiology (IR) in the management of adult patients with hepatocellular carcinoma (HCC), the role of IR for pediatric liver tumors is still being established. This is, in part, due to the rarity and heterogeneity of pediatric liver tumors as well as the limited literature supporting liver-directed therapies for children. In addition, hepatoblastoma, the most common primary pediatric liver tumor, carries a good prognosis with current surgical and systemic treatment options directed by well-established clinical trials. Still, a subset of patients will not be amenable to operative treatment, and other pediatric liver tumors, such as HCC, portend a dismal prognosis. These settings offer opportunities for growth of pediatric IR and to provide services that improve the lives of children. The purpose of this article is to review the role of IR in pediatric liver cancer, including biopsy recommendations set forth by current clinical trials, transarterial chemoembolization and radioembolization, and percutaneous ablation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.